Study Design
This was a single-center, phase 2 trial using a Simon’s optimal two-stage designThe study was approved by the institutional review board. It was conducted in accordance with the Declaration of Helsinki and according to Good Clinical Practice. All patients provided written, informed consent before enrolment. Subjects were enrolled between December 2020 and July 2022.